beta
How it worksFor specialistsKnowledgeBlogFAQ
Sign in
NutriFit®

Product

Knowledge baseBlogRecipesOur pricingNutriFit calculatorsMCP Server

Documents

Privacy policyUser agreementPublic offer

Help

Support
© 2026 NutriFit. All rights reserved.V1.0.2348 · 2025–2026

All materials

CategoriesCourses
NutritionSupplementsBiohackingMental health

Material type

All materialsKnowledgeNews

Area

NutritionSupplementsBiohackingMental healthLabs and diagnosticsSleep
Reset filters
General

Popular tags

#митохондрии#supplement-safety#витамин B6#витамин D#гемоглобин#нейропатия#фармакокинетика#микробиота#AMPK#Для специалистов#эндотелий#иммунитет
Reset filters
Knowledge · Nutrition

Berberine and the Intestinal Barrier: AMPK, Tight Junctions, and the Limits of Clinical Evidence

How berberine affects AMPK, MLCK, ZO-1, and occludin in epithelial injury models; pharmacokinetics, separate IBS-D and ulcerative-colitis findings, and limits of clinical inference.

October 9, 2026
Knowledge · Nutrition

Dietary lectins: glycan binding, the intestinal barrier, and real-world exposure

How WGA and PHA bind glycans, what permeability models show, why undercooked beans can cause acute poisoning, and why clinical effects of cooked wheat remain uncertain.

October 9, 2026
Knowledge · Nutrition

Intestinal alkaline phosphatase: LPS chemistry, the microbiota, and clinical limits

ALPI enzymology, lipid A and ATP dephosphorylation, microbiota, regulation, and human trials: negative primary outcomes in STOP-AKI and REVIVAL and limits of ulcerative-colitis data.

October 9, 2026